Summary of Product Characteristics
last updated on the eMC:
03/10/2003
|
SPC
|
Modrasone Cream, Ointment
|
Go to top of the page | Modrasone CreamModrasone Ointment | |
Go to top of the page | Alclometasone Dipropionate 0.05% w/w | |
Go to top of the page | Cream/Ointment for topical use. | |
Go to top of the pageGo to top of the page | Alclometasone dipropionate is a non-fluorinated topically active synthetic corticosteroid. Modrasone is indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. | |
Go to top of the page | Adult and Children: A thin film of Modrasone should be applied to the affected area two or three times daily or as directed by the physician. Massage gently into the skin until the medication disappears. | |
Go to top of the page | Hypersensitivity to any of the ingredients; rosacea; acne and perioral dermatitis; tuberculous and viral lesions of the skin, particularly Herpes Simplex; vaccinia; varicella.Modrasone should not be used in fungal or bacterial skin infections. | |
Go to top of the page | As with all topical steroids, long term continuous therapy should be avoided where possible, particularly in infants and children as adrenal suppression may occur even without occlusion. In infants the napkin may act as an occlusive dressing and thus increase absorption. | |
Go to top of the pageGo to top of the page | Topical administration of corticosteroids to pregnant animals can cause abnormalities in foetal development. The relevance of this finding to human beings has not been established; however, topical steroids should not be used extensively in pregnancy i.e. in large amounts or for long periods.It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Modrasone should be administered to nursing mothers only after careful consideration of the benefit/risk relationship. | |
Go to top of the pageGo to top of the page | Excessive prolonged use may result in local atrophy of the skin, striae and superficial vascular dilation, particularly on the face. | |
Go to top of the page | Excessive prolonged use of topical corticosteroids can suppress pituitary-adrenal function resulting in secondary adrenal insufficiency which is usually reversible. In such cases appropriate symptomatic treatment is indicated. In cases of chronic toxicity, corticosteroids should be withdrawn.The steroid content is so low as to have little or no effect in the unlikely event of accidental oral ingestion. | |
Go to top of the pageGo to top of the page | Alclometasone dipropionate is a non-fluorinated, topically active synthetic corticosteroid. Alclometasone dipropionate suppresses local inflammation at doses producing minimal systemic effects. Studies have shown alclometasone dipropionate to be approximately 2/3 as potent as betamethasone valerate and 60 x as potent as hydrocortisone. | |
Go to top of the page | Not applicable in view of topical action and application. | |
Go to top of the page | Modrasone appears to be a relatively non-toxic and non-irritating drug product that produces no unusual or unexpected teratologic effects in laboratory animals. A wide margin of safety was demonstrated in all species studied. Acute oral and intraperitoneal doses more than 3,000 times the proposed topical human dose were without any toxicologically significant effects. | |
Go to top of the pageGo to top of the page | Cream:Propylene Glycol Ph EurWhite Soft Paraffin BPCetostearyl Alcohol BPGlyceryl stearate PEG 100 stearatePolyoxyethylene (20) cetyl etherSodium dihydrogenium phosphate dihydrate4-Chloro-M-Cresol BPPhosphoric Acid Ph EurPurified Water Ph EurOintment:Hexylene glycolPropylene glycol monostearateWhite Beeswax BPWhite Soft Paraffin BP | |
Go to top of the pageGo to top of the page | Cream and Ointment: 60 months | |
Go to top of the pageGo to top of the page | Cream and Ointment: Aluminium tubes with white LDPE caps. Pack size: 50g | |
Go to top of the pageGo to top of the pageGo to top of the page | Schering-Plough LtdShire ParkWelwyn Garden CityHertfordshireAL7 1TW | |
Go to top of the page | Cream: PL 0201/0060Ointment: PL 0201/0061 | |
Go to top of the pageGo to top of the page | 5 March 1996Legal Category POMDistributed in the UK by: PLIVA Pharma Ltd., Vision House, Bedford Road, Petersfield, Hampshire GU32 3QB | |
More information about this product
Link to this document from your website: http://emc.medicines.org.uk/medicine/510/SPC/Modrasone Cream, Ointment/